Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17085654

Clin. Cancer Res. 2006 Nov 1 12 21 6415-20

Download in:

View as

General Info

PMID
17085654